Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Wohl

Showing results (91-100 of 185) with videos related to

Pageof 19
Sort By:
Journal of Crohn'S & Colitis|October 21, 2020
Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19Corey A Siegel, Britt Christensen, Asher Kornbluth, et al.
Plos One|May 15, 2014
Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trialDavid A Wohl, Laveeza Bhatti, Catherine B Small, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 24, 2018
Medicaid Enrollment among Prison Inmates in a Non-expansion State: Exploring Predisposing, Enabling, and Need Factors Related to Enrollment Pre-incarceration and Post-ReleaseCatherine A Grodensky, David L Rosen, Colleen M Blue, et al.
The Journal of Infectious Diseases|December 10, 2016
Validation of the Cepheid GeneXpert for Detecting Ebola Virus in SemenAmy James Loftis, Saturday Quellie, Kelly Chason, et al.
Antiviral Therapy|August 12, 2015
Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week resultsMichelle A Floris-Moore, Katie Mollan, Aimee M Wilkin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2021
Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational CohortEssy Mozaffari, Aastha Chandak, Zhiji Zhang, et al.
Journal of Clinical Apheresis|July 10, 2016
Apheresis for collection of Ebola convalescent plasma in LiberiaJerry F Brown, Kathleen Rowe, Peter Zacharias, et al.
Virulence|May 8, 2012
Tracking linkage to HIV care for former prisoners: a public health priorityBrian T Montague, David L Rosen, Liza Solomon, et al.
AIDS Research and Human Retroviruses|March 27, 2009
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758Charles B Hicks, Edwin DeJesus, Louis M Sloan, et al.
Influenza and Other Respiratory Viruses|March 11, 2020
Burden of respiratory viral infection in persons with human immunodeficiency virusSubhashini A Sellers, Kenton L Dover, Aubrey G Bailey, et al.
Pageof 19

Showing results (91-100 of 185) with videos related to

Sort By:
Pageof 19
Journal of Crohn'S & Colitis|October 21, 2020
Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19Corey A Siegel, Britt Christensen, Asher Kornbluth, et al.
Plos One|May 15, 2014
Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trialDavid A Wohl, Laveeza Bhatti, Catherine B Small, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|June 24, 2018
Medicaid Enrollment among Prison Inmates in a Non-expansion State: Exploring Predisposing, Enabling, and Need Factors Related to Enrollment Pre-incarceration and Post-ReleaseCatherine A Grodensky, David L Rosen, Colleen M Blue, et al.
The Journal of Infectious Diseases|December 10, 2016
Validation of the Cepheid GeneXpert for Detecting Ebola Virus in SemenAmy James Loftis, Saturday Quellie, Kelly Chason, et al.
Antiviral Therapy|August 12, 2015
Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week resultsMichelle A Floris-Moore, Katie Mollan, Aimee M Wilkin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2021
Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational CohortEssy Mozaffari, Aastha Chandak, Zhiji Zhang, et al.
Journal of Clinical Apheresis|July 10, 2016
Apheresis for collection of Ebola convalescent plasma in LiberiaJerry F Brown, Kathleen Rowe, Peter Zacharias, et al.
Virulence|May 8, 2012
Tracking linkage to HIV care for former prisoners: a public health priorityBrian T Montague, David L Rosen, Liza Solomon, et al.
AIDS Research and Human Retroviruses|March 27, 2009
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758Charles B Hicks, Edwin DeJesus, Louis M Sloan, et al.
Influenza and Other Respiratory Viruses|March 11, 2020
Burden of respiratory viral infection in persons with human immunodeficiency virusSubhashini A Sellers, Kenton L Dover, Aubrey G Bailey, et al.
Pageof 19